Court rules companies can't import Gilead medications from overseas in blow to AFP health programs
A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.
This is a summary aggregated from CNBC. Read the complete article on the original site:
Read full article at CNBC
